Displaying 1 - 20 of 87 results
Released Company Title Industry Topic
11 Jul 2019
09:30 CEST
THERANEXUS THERANEXUS RAISES APPROXIMATELY 2.2 MILLION EUROS IN A PLACEMENT RESERVED TO A CATEGORY OF PERSONS Biotechnology Other subject
11 Jul 2019
09:05 CEST
THERANEXUS THERANEXUS LEVE 2,2 MILLIONS D'EUROS DANS LE CADRE D'UN PLACEMENT RESERVE A UNE CATEGORIE DE PERSONNES Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
10 Jul 2019
18:50 CEST
THERANEXUS THERANEXUS ANNOUNCES THE LAUNCH OF A CAPITAL INCREASE BY PRIVATE PLACEMENT FOR A MAXIMUM AMOUNT OF EURO 4 MILLION Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
10 Jul 2019
18:45 CEST
THERANEXUS Erratum- THERANEXUS ANNONCE LE LANCEMENT D'UNE AUGMENTATION DE CAPITAL PAR PLACEMENT RÉSERVÉ, D'UN MONTANT MAXIMAL DE 4 MILLIONS D'EUROS Biotechnology Other subject
10 Jul 2019
18:05 CEST
THERANEXUS THERANEXUS ANNONCE LE LANCEMENT D'UNE AUGMENTATION DE CAPITAL PAR PLACEMENT RÉSERVÉ, D'UN MONTANT MAXIMAL DE 4 MILLIONS D'EUROS Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
08 Jul 2019
18:50 CEST
THERANEXUS THERANEXUS REPORTS CASH POSITION AS OF JUNE 30, 2019 Biotechnology Other subject
08 Jul 2019
18:35 CEST
THERANEXUS THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 30 JUIN 2019 Biotechnology Other subject
27 Jun 2019
18:00 CEST
THERANEXUS Theranexus and Beyond Batten Disease Foundation (BBDF) announce agreement in principle to develop and market Batten disease drug candidate BBDF 101 Biotechnology Other subject
27 Jun 2019
18:00 CEST
THERANEXUS Theranexus et " Beyond Batten Disease Foundation " (BBDF) annoncent un accord de principe pour le développement et la commercialisation du candidat médicament BBDF 101 dans la maladie de Batten Biotechnology Other subject
20 Jun 2019
07:30 CEST
THERANEXUS THERANEXUS INVITED TO JOIN IN THE HEALTHTECH INVESTOR DAYS (HTID) 24 and 25 JUNE IN PARIS Biotechnology Other subject
20 Jun 2019
07:30 CEST
THERANEXUS THERANEXUS PARTICIPERA AU HEALTHTECH INVESTOR DAYS (HTID) LES 24 ET 25 JUIN À PARIS Biotechnology Other subject
04 Jun 2019
18:00 CEST
THERANEXUS THERANEXUS ANNOUNCES THE FORMATION OF ITS SCIENTIFIC BOARD Biotechnology Other subject
04 Jun 2019
18:00 CEST
THERANEXUS THERANEXUS ANNONCE LA CONSTITUTION DE SON CONSEIL SCIENTIFIQUE Biotechnology Other subject
23 May 2019
08:00 CEST
THERANEXUS THERANEXUS PRÉSENTERA DE NOUVELLES DONNÉES SUR LES INTERACTIONS NEUROGLIALES LORS DE DEUX ÉVÈNEMENTS SCIENTIFIQUES Biotechnology Other subject
23 May 2019
08:00 CEST
THERANEXUS THERANEXUS TO PRESENT NEW DATA ON NEURON-GLIA INTERACTIONS AT TWO SCIENTIFIC EVENTS Biotechnology Other subject
30 Apr 2019
18:30 CEST
THERANEXUS DOCUMENT DE REFERENCE 2018 Biotechnology Legal
30 Apr 2019
18:30 CEST
THERANEXUS MISE À DISPOSITION DU DOCUMENT DE RÉFÉRENCE 2018 Biotechnology Other subject
24 Apr 2019
07:30 CEST
THERANEXUS THERANEXUS ANNONCE LA DÉLIVRANCE EN CHINE D'UN BREVET COUVRANT SON CANDIDAT MÉDICAMENT THN102 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
24 Apr 2019
07:30 CEST
THERANEXUS THERANEXUS ANNOUNCES ISSUANCE OF CHINESE PATENT COVERING ITS DRUG CANDIDATE THN102 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
17 Apr 2019
07:30 CEST
THERANEXUS THERANEXUS PROVIDES 2018 FULL-YEAR RESULTS AND UPDATE ON ACTIVITIES Biotechnology Commercial results, Income, Sales